Geneius invests in new automation

Geneius attains UKAS accreditation for the automation of its Geneius rapID testing platform.

The popularity of Geneius’ rapID testing platform for Listeria has required the company to invest in robotics to facilitate automated high throughput DNA extraction. The new technology and the chemistry associated has been awarded UKAS accreditation and is now in use operationally every day. The technology increases the capacity of the laboratory and delivers even greater reliability and efficiency.

If you would like to know more please call 0845 112 0 112.